University of Pennsylvania Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.SBRT With Atezo/Bev for HCC
Condition: Hepatocellular Carcinoma Intervention: Biological: SBRT + atezolizumab and bevacizumab Sponsor: Abramson Cancer Center of the University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2022 Category: Research Source Type: clinical trials
